SEC Filing Analysis: ARTIVION, INC. (AORT)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Commercial Officer conducted a pre-planned exercise of stock options and sold the resulting shares for a total of $574,449, representing a negligible fraction of the company's market capitalization.
• Market Impact: Neutral. The transaction was executed under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on recent material non-public information.

Company Information

Field	Value
Company	ARTIVION, INC.
Ticker Symbol	AORT
CIK	0000784199
Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Insider Information

Field	Value
Name	Davis John E
CIK	0001653206
Title/Position	Chief Commercial Officer
Relationship	Officer

Transaction Details

This filing reports a series of 'exercise-and-sell' transactions. The insider exercised options to acquire shares and immediately sold them. The most relevant transaction for market signaling is the sale.

Field	Value
Form Type	4
Transaction Date	2025-11-14, 2025-11-17
Transaction Code	M (Exercise), S (Sale)
Security Type	Common Stock
Shares Involved	12,787 (Total Sold)
Price Per Share	$44.67 - $45.17 (Sale Prices)
Total Value	$574,449 (Total Sale Value)
Shares Owned After	198,842
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$574,449
% of Market Cap	0.027%
Shares Transacted	12,787
% of Shares Outstanding	0.027%
Post-Transaction Ownership	198,842 shares (0.42% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Artivion has a market capitalization of $2.17 billion. The total sale value of ~$574k is insignificant in this context.
• Ownership Concentration: The sale represented approximately 6% of the insider's prior holdings. The insider retains a significant position of 198,842 shares, valued at over $8.9 million based on recent sale prices.
• Dilution Impact: The transaction involved exercising previously granted options. The number of shares (12,787) is negligible (0.027%) compared to the 47.2 million shares outstanding, resulting in no meaningful dilution.
• Transaction Significance: Both the transaction value as a percentage of market cap (0.027%) and the shares as a percentage of outstanding shares (0.027%) are well below the 0.1% threshold for moderate significance. This is a routine, low-impact transaction.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is small relative to the company's market cap and was conducted under a pre-arranged 10b5-1 plan. Such plans are common for executives to liquidate portions of their equity compensation over time for financial planning and tax purposes. It is not considered a signal of the insider's current view on the company's future performance.

Volume & Sentiment

• Expected Volume Impact: Minimal. The transaction size is too small to materially affect trading volume.
• Sentiment Indicator: Neutral. The market generally disregards pre-planned 10b5-1 sales unless they are exceptionally large or frequent.

Additional Context

Transaction Notes

• Special Circumstances: The filing explicitly states in a footnote that the option exercise and subsequent sale were made pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025. This removes ambiguity about the insider's motivation, pointing towards a pre-scheduled liquidation rather than a reaction to current events.